A.I. Learns to Write in DNA
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
According to Yahoo Finance, Google DeepMind is disbanding the AlphaFold team — the research group that cracked one of biology's hardest problems and earned a Nobel Prize for it — as the company redirects resources toward its Gemini consumer AI.
AlphaFold's work transformed drug discovery by predicting the three-dimensional structure of proteins with a precision that took decades of conventional lab work to approximate. The team's Nobel recognition was a rare moment when a technology company's research output was judged on the same terms as academic science.
The pivot to Gemini reveals where Google's competitive priorities now sit: consumer AI products that can go head-to-head with other large language model deployments, rather than scientific infrastructure that pays dividends over years. Resource decisions of this scale are rarely reversed, making this more than a personnel story — it's a statement about where the company believes research returns are headed.
All comments are reviewed before appearing. Keep it respectful.
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
The Trump administration has no idea on how to handle open-source and open-weight AI models from China.
Google is consolidating AI leadership in California but the reorganization is pushing out the engineers who built its AI division